IMAAVY Trademark

Trademark Overview

On Monday, July 17, 2023, a trademark application was filed for IMAAVY with the United States Patent and Trademark Office. The USPTO has given the IMAAVY trademark a serial number of 98087543. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, October 9, 2025. This trademark is owned by Johnson & Johnson. The IMAAVY trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases and central nervous system diseases
imaavy

General Information

Serial Number98087543
Word MarkIMAAVY
Filing DateMonday, July 17, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, October 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2024

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases and central nervous system diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 15, 2023
Primary Code005
First Use Anywhere DateWednesday, May 7, 2025
First Use In Commerce DateWednesday, May 7, 2025

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Thursday, July 20, 2023NEW APPLICATION ENTERED
Tuesday, August 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 28, 2023ASSIGNED TO EXAMINER
Monday, October 30, 2023SUSPENSION LETTER WRITTEN
Monday, October 30, 2023LETTER OF SUSPENSION E-MAILED
Monday, October 30, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 3, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 22, 2024ASSIGNED TO LIE
Friday, March 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 18, 2024SUSPENSION LETTER WRITTEN
Thursday, July 18, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 18, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, September 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 2, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 22, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 8, 2025USE AMENDMENT FILED
Thursday, May 8, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, September 30, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 9, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 9, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

imaavy diseases inflammatory central nervous system immune auto pharmaceutical preparations prevention